1 Lecanemab has been approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, the United Arab Emirates and Great Britain and ... and leverage different modalities to advance first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback